XML 36 R2.htm IDEA: XBRL DOCUMENT
v3.25.4

Pay vs Performance Disclosure - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2025 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Pay vs Performance Disclosure |  |  |  |  |
Pay vs Performance Disclosure, Table | 2025 Pay Versus Performance Table The following table sets forth additional compensation information of our Principal Executive Officer (“PEO”) and our non-PEO Named Executive Officers (“non-PEO NEOs”) along with total shareholder return, net income attributable to HCA Healthcare, Inc. and adjusted EBITDA performance results for fiscal years 2025, 2024, 2023, 2022 and 2021. “Compensation actually paid” does not represent the value of cash and shares of the Company’s common stock received by named executive officers during the year, but rather it is an amount calculated under SEC rules and includes, among other things, year-over-year changes in the value of unvested equity based awards. As a result of the calculation methodology required by the SEC, “Compensation actually paid” amounts differ from compensation actually received by the individuals and the compensation decisions described in the “Compensation Discussion and Analysis” section above.
Year |  | Summary Compensation Table Total for PEO (1) |  | Compensation Actually Paid to PEO (2)(3) |  | Average Summary Compensation Table Total for non-PEO NEOs (1) |  | Average Compensation Actually Paid to non-PEO NEOs (2)(3) |  | Value of Initial Fixed $100 Investment Based On: |  | Net Income Attributable to HCA Healthcare, Inc. |  | Adjusted EBITDA (10)
| Total Shareholder Return |  | Peer Group Total Shareholder Return (9)
2025 (4) |  |  | $ | 26,456,606 |  |  |  | $ | 78,235,064 |  |  |  | $ | 8,190,607 |  |  |  | $ | 16,384,912 |  |  |  | $ | 296.34 |  |  |  | $ | 148.36 |  |  |  | $ | 6,784,000,000 |  |  |  | $ | 15,566,000,000 |
2024 (5) |  |  | $ | 23,799,137 |  |  |  | $ | 40,146,727 |  |  |  | $ | 6,121,496 |  |  |  | $ | 6,090,844 |  |  |  | $ | 189.11 |  |  |  | $ | 129.46 |  |  |  | $ | 5,760,000,000 |  |  |  | $ | 13,882,000,000 |
2023 (6) |  |  | $ | 21,315,984 |  |  |  | $ | 23,591,845 |  |  |  | $ | 6,861,426 |  |  |  | $ | 7,050,413 |  |  |  | $ | 169.23 |  |  |  | $ | 126.21 |  |  |  | $ | 5,242,000,000 |  |  |  | $ | 12,726,000,000 |
2022 (7) |  |  | $ | 14,637,726 |  |  |  | $ | 9,582,202 |  |  |  | $ | 5,166,993 |  |  |  | $ | 3,405,676 |  |  |  | $ | 148.69 |  |  |  | $ | 123.67 |  |  |  | $ | 5,643,000,000 |  |  |  | $ | 12,067,000,000 |
2021 (8) |  |  | $ | 20,635,260 |  |  |  | $ | 84,568,577 |  |  |  | $ | 5,999,564 |  |  |  | $ | 19,628,647 |  |  |  | $ | 157.59 |  |  |  | $ | 126.13 |  |  |  | $ | 6,956,000,000 |  |  |  | $ | 12,644,000,000 |
(1) | Named executive officers included in the above compensation columns reflect the following:
|  | Year |  | PEO |  | Non-PEO NEOs |  |
|  | 2025 |  | Hazen |  | Marks, Foster, McAlevey, Cuffe
|  | 2024 |  | Hazen |  | Rutherford*, Marks*, Foster, McAlevey, Cuffe *  Effective 5/1/2024, Rutherford retired from and Marks was appointed to the Executive Vice President and Chief Financial Officer position.
|  | 2023 |  | Hazen |  | Rutherford, Foster, Akdamar, McManus |  |
|  | 2022 |  | Hazen |  | Rutherford, Foster, Hall, McAlevey |  |
|  | 2021 |  | Hazen |  | Rutherford, Foster, Hall, Cuffe |  |
(2) | Fair value or change in fair value, as applicable, of equity awards in the “Actually Paid” columns was determined by reference to (1) for PSU awards, closing price on applicable year-end date(s) multiplied by the probability of achievement as of each such date or, in the case of vesting dates, the actual shares earned multiplied by the vesting price, (2) for SAR awards, a Black-Scholes value as of the applicable year-end or vesting date(s), determined based on the same methodology as used to determine grant date fair value for the applicable grant and (3) for RSU awards, the closing price on applicable year-end date(s) or, in the case of vesting dates, the actual vesting price.
(3) | For the portion of “Actually Paid” compensation that is based on year-end stock prices, the following prices were used: $466.86 for 2025 (closing price as of 12/31/25), $300.15 for 2024 (closing price as of 12/31/24), $270.68 for 2023 (closing price as of 12/29/23), $239.96 for 2022 (closing price as of 12/30/22) and $256.92 for 2021 (closing price as of 12/31/21).
(4) | 2025 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2025 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2025 Summary Compensation Table Total |  | $ | 26,456,606 |  |  | $ | 8,190,607 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 1,934,400 |  |  | $ | 1,681,853 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 734,679 |  |  | $ | 230,134 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 16,988,633 |  |  | $ | 3,115,621 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/25 |  | $ | 27,194,526 |  |  | $ | 4,987,299 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/25 |  | $ | 31,066,347 |  |  | $ | 5,728,425 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 11,676,197 |  |  | $ | 2,033,581 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,077 |  |  | $ | 76,670 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 464,819 |  |  | $ | 89,010 |
2025 Compensation Actually Paid |  | $ | 78,235,064 |  |  | $ | 16,384,912 |
(5) | 2024 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2024 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  | Average non-PEO NEOs
2024 Summary Compensation Table Total |  |  | $ | 23,799,137 |  |  |  | $ | 6,121,496 |
Less: Change in Pension & Deferred Compensation Plans |  |  | $ | 372,138 |  |  |  | $ | 265,350 |
Add: Service Cost of Pension & Deferred Compensation Plans |  |  | $ | 689,830 |  |  |  | $ | 149,373 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  | — |  |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  |  | — |  |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  |  | $ | 16,580,668 |  |  |  | $ | 3,423,531 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/24 |  |  | $ | 17,195,564 |  |  |  | $ | 2,640,576 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/24 |  |  | $ | 10,479,537 |  |  |  | $ | 1,434,246 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  |  | — |  |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  |  | $ | 4,662,911 |  |  |  | $ | 668,465 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions* |  |  |  | — |  |  |  | $ | 1,267,373 |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  |  | $ | 96,234 |  |  |  | $ | 13,211 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  |  | $ | 368,788 |  |  |  | $ | 46,153 |
2024 Compensation Actually Paid |  |  | $ | 40,146,727 |  |  |  | $ | 6,090,844 |
| * | Mr. Rutherford forfeited certain unvested equity awards as a result of his 5/1/2024 retirement.
(6) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  |  |  |  |  |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,447 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(7) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(8) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
(9) | The Peer Group reflected in the Peer Group Total Shareholder Return is the S&P Health Care Index, as reflected in our 2025 Annual Report on Form the 10-K pursuant to Item 201(e) of Regulation S-K. Each year reflects the cumulative total return assuming $100 invested on December 31, 2020 in our common stock and in the S&P Health Care Index, including the subsequent reinvestment of dividends.
(10) | Adjusted EBITDA was selected by the Compensation Committee as the Company-Selected Measure (“CSM”). It is a non-Generally Accepted Accounting Principles (“GAAP”) financial measure defined as income before depreciation and amortization, interest expense, losses and gains on sales of facilities, losses on retirement of debt, provision for income taxes and net income attributable to noncontrolling interests. Reconciliations of Adjusted EBITDA to the most directly comparable financial measure calculated in accordance with GAAP are included in Appendix A.
Company Selected Measure Name | Adjusted EBITDA |  |  |  |
Named Executive Officers, Footnote |
(1) | Named executive officers included in the above compensation columns reflect the following:
|  | Year |  | PEO |  | Non-PEO NEOs |  |
|  | 2025 |  | Hazen |  | Marks, Foster, McAlevey, Cuffe
|  | 2024 |  | Hazen |  | Rutherford*, Marks*, Foster, McAlevey, Cuffe *  Effective 5/1/2024, Rutherford retired from and Marks was appointed to the Executive Vice President and Chief Financial Officer position.
|  | 2023 |  | Hazen |  | Rutherford, Foster, Akdamar, McManus |  |
|  | 2022 |  | Hazen |  | Rutherford, Foster, Hall, McAlevey |  |
|  | 2021 |  | Hazen |  | Rutherford, Foster, Hall, Cuffe |  |
Peer Group Issuers, Footnote | The Peer Group reflected in the Peer Group Total Shareholder Return is the S&P Health Care Index, as reflected in our 2025 Annual Report on Form the 10-K pursuant to Item 201(e) of Regulation S-K. Each year reflects the cumulative total return assuming $100 invested on December 31, 2020 in our common stock and in the S&P Health Care Index, including the subsequent reinvestment of dividends. |  |  |  |
PEO Total Compensation Amount | $ 26,456,606 | $ 23,799,137 | $ 21,315,984 | $ 14,637,726 | $ 20,635,260
PEO Actually Paid Compensation Amount | $ 78,235,064 | 40,146,727 | 23,591,845 | 9,582,202 | 84,568,577
Adjustment To PEO Compensation, Footnote |
(4) | 2025 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2025 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2025 Summary Compensation Table Total |  | $ | 26,456,606 |  |  | $ | 8,190,607 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 1,934,400 |  |  | $ | 1,681,853 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 734,679 |  |  | $ | 230,134 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 16,988,633 |  |  | $ | 3,115,621 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/25 |  | $ | 27,194,526 |  |  | $ | 4,987,299 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/25 |  | $ | 31,066,347 |  |  | $ | 5,728,425 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 11,676,197 |  |  | $ | 2,033,581 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,077 |  |  | $ | 76,670 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 464,819 |  |  | $ | 89,010 |
2025 Compensation Actually Paid |  | $ | 78,235,064 |  |  | $ | 16,384,912 |
(5) | 2024 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2024 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  | Average non-PEO NEOs
2024 Summary Compensation Table Total |  |  | $ | 23,799,137 |  |  |  | $ | 6,121,496 |
Less: Change in Pension & Deferred Compensation Plans |  |  | $ | 372,138 |  |  |  | $ | 265,350 |
Add: Service Cost of Pension & Deferred Compensation Plans |  |  | $ | 689,830 |  |  |  | $ | 149,373 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  | — |  |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  |  | — |  |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  |  | $ | 16,580,668 |  |  |  | $ | 3,423,531 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/24 |  |  | $ | 17,195,564 |  |  |  | $ | 2,640,576 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/24 |  |  | $ | 10,479,537 |  |  |  | $ | 1,434,246 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  |  | — |  |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  |  | $ | 4,662,911 |  |  |  | $ | 668,465 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions* |  |  |  | — |  |  |  | $ | 1,267,373 |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  |  | $ | 96,234 |  |  |  | $ | 13,211 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  |  | $ | 368,788 |  |  |  | $ | 46,153 |
2024 Compensation Actually Paid |  |  | $ | 40,146,727 |  |  |  | $ | 6,090,844 |
| * | Mr. Rutherford forfeited certain unvested equity awards as a result of his 5/1/2024 retirement.
(6) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  |  |  |  |  |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,447 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(7) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(8) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
Non-PEO NEO Average Total Compensation Amount | $ 8,190,607 | 6,121,496 | 6,861,426 | 5,166,993 | 5,999,564
Non-PEO NEO Average Compensation Actually Paid Amount | $ 16,384,912 | 6,090,844 | 7,050,413 | 3,405,676 | 19,628,647
Adjustment to Non-PEO NEO Compensation Footnote |
(4) | 2025 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2025 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2025 Summary Compensation Table Total |  | $ | 26,456,606 |  |  | $ | 8,190,607 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 1,934,400 |  |  | $ | 1,681,853 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 734,679 |  |  | $ | 230,134 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 16,988,633 |  |  | $ | 3,115,621 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/25 |  | $ | 27,194,526 |  |  | $ | 4,987,299 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/25 |  | $ | 31,066,347 |  |  | $ | 5,728,425 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 11,676,197 |  |  | $ | 2,033,581 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,077 |  |  | $ | 76,670 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 464,819 |  |  | $ | 89,010 |
2025 Compensation Actually Paid |  | $ | 78,235,064 |  |  | $ | 16,384,912 |
(5) | 2024 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2024 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  | Average non-PEO NEOs
2024 Summary Compensation Table Total |  |  | $ | 23,799,137 |  |  |  | $ | 6,121,496 |
Less: Change in Pension & Deferred Compensation Plans |  |  | $ | 372,138 |  |  |  | $ | 265,350 |
Add: Service Cost of Pension & Deferred Compensation Plans |  |  | $ | 689,830 |  |  |  | $ | 149,373 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  | — |  |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  |  | — |  |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  |  | $ | 16,580,668 |  |  |  | $ | 3,423,531 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/24 |  |  | $ | 17,195,564 |  |  |  | $ | 2,640,576 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/24 |  |  | $ | 10,479,537 |  |  |  | $ | 1,434,246 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  |  | — |  |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  |  | $ | 4,662,911 |  |  |  | $ | 668,465 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions* |  |  |  | — |  |  |  | $ | 1,267,373 |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  |  | $ | 96,234 |  |  |  | $ | 13,211 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  |  | $ | 368,788 |  |  |  | $ | 46,153 |
2024 Compensation Actually Paid |  |  | $ | 40,146,727 |  |  |  | $ | 6,090,844 |
| * | Mr. Rutherford forfeited certain unvested equity awards as a result of his 5/1/2024 retirement.
(6) | 2023 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2023 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2023 Summary Compensation Table Total |  | $ | 21,315,984 |  |  | $ | 6,861,426 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 264,662 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 723,544 |  |  | $ | 135,006 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  |  |  |  |  |  |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 14,200,216 |  |  | $ | 3,489,375 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/23 |  | $ | 15,028,391 |  |  | $ | 3,692,881 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/23 |  | $ | (2,830,010 | ) |  | $ | (482,970 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | 3,842,051 |  |  | $ | 642,447 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 514,566 |  |  | $ | 85,739 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 226,667 |  |  | $ | 41,399 |
2023 Compensation Actually Paid |  | $ | 23,591,845 |  |  | $ | 7,050,413 |
(7) | 2022 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2022 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2022 Summary Compensation Table Total |  | $ | 14,637,726 |  |  | $ | 5,166,993 |
Less: Change in Pension & Deferred Compensation Plans |  |  | — |  |  | $ | 276,883 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 952,610 |  |  | $ | 182,990 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 12,055,290 |  |  | $ | 3,063,442 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/22 |  | $ | 13,374,858 |  |  | $ | 2,698,985 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/22 |  | $ | (3,338,709 | ) |  | $ | (573,313 | )
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date |  | $ | (3,998,784 | ) |  | $ | (737,029 | )
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 435,499 |  |  | $ | 73,188 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 445,290 |  |  | $ | 80,563 |
2022 Compensation Actually Paid |  | $ | 9,582,202 |  |  | $ | 3,405,676 |
(8) | 2021 “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to non-PEO NEOs” reflects the following adjustments from 2021 Total Compensation reported in the Summary Compensation Table:
|  | PEO |  |  | Average non-PEO NEOs |
2021 Summary Compensation Table Total |  | $ | 20,635,260 |  |  | $ | 5,999,564 |
Less: Change in Pension & Deferred Compensation Plans |  | $ | 451,661 |  |  | $ | 103,724 |
Add: Service Cost of Pension & Deferred Compensation Plans |  | $ | 980,231 |  |  | $ | 207,139 |
Add: Prior Service Cost of Pension & Deferred Compensation Plans |  |  | — |  |  |  | — |
Add: Above-Market or Preferential Earnings on Deferred Compensation |  |  | — |  |  |  | — |
Less: Equity Award Amounts Reported in Summary Compensation Table |  | $ | 13,870,607 |  |  | $ | 3,233,944 |
Add: FMV of Equity Awards Granted During Current Year & Outstanding/Unvested @ 12/31/21 |  | $ | 34,793,801 |  |  | $ | 7,765,175 |
Add: Change in FMV Equity Awards Granted in Prior Years & Outstanding/Unvested @ 12/31/21 (4) |  | $ | 33,207,890 |  |  | $ | 7,116,946 |
Add: FMV of Equity Awards Granted and Vested in Current Year @ Vesting Date |  |  | — |  |  |  | — |
Add: Change in FMV of Equity Awards Granted in Prior Years @ Vesting Date (4) |  | $ | 9,064,316 |  |  | $ | 1,834,093 |
Less: FMV of Equity Awards @ the End of the Prior Year Failing to Meet Vesting Conditions |  |  | — |  |  |  | — |
Less: Dollar Value of Equivalent Payments Reported in Summary Compensation Table |  | $ | 335,908 |  |  | $ | 67,999 |
Add: Dollar Value of Dividends Paid Prior to Vesting Date |  | $ | 545,255 |  |  | $ | 111,397 |
2021 Compensation Actually Paid |  | $ | 84,568,577 |  |  | $ | 19,628,647 |
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |  |
Tabular List, Table | Measures that were most important to the last fiscal year. The following performan ce m easures reflect the Company’s most important performance measures in effect for 2025, as further described and defined in the Compensation Discussion and Analysis under “Elements of Compensation — Annual Incentive Compensation: PEP” and “Elements of Compensation — Long-Term Equity Incentive Awards — Performance Share Units.”
| • |  | Adjusted EBITDA
| • |  | Earnings Per Share
| • |  | Quality of Care
| • |  | Patient Experience
Total Shareholder Return Amount | $ 296.34 | 189.11 | 169.23 | 148.69 | 157.59
Peer Group Total Shareholder Return Amount | 148.36 | 129.46 | 126.21 | 123.67 | 126.13
Net Income (Loss) | $ 6,784,000,000 | $ 5,760,000,000 | $ 5,242,000,000 | $ 5,643,000,000 | $ 6,956,000,000
Company Selected Measure Amount | 15,566,000,000 | 13,882,000,000 | 12,726,000,000 | 12,067,000,000 | 12,644,000,000
PEO Name | Hazen |  |  |  |
Measure:: 1 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Adjusted EBITDA |  |  |  |
Non-GAAP Measure Description | It is a non-Generally Accepted Accounting Principles (“GAAP”) financial measure defined as income before depreciation and amortization, interest expense, losses and gains on sales of facilities, losses on retirement of debt, provision for income taxes and net income attributable to noncontrolling interests. Reconciliations of Adjusted EBITDA to the most directly comparable financial measure calculated in accordance with GAAP are included in Appendix A. |  |  |  |
Measure:: 2 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Earnings Per Share |  |  |  |
Measure:: 3 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Quality of Care |  |  |  |
Measure:: 4 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Patient Experience |  |  |  |
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ (1,934,400) | $ (372,138) |  |  | $ (451,661)
PEO | Pension Adjustments Prior Service Cost |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 734,679 | 689,830 | $ 723,544 | $ 952,610 | 980,231
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (16,988,633) | (16,580,668) | (14,200,216) | (12,055,290) | (13,870,607)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 27,194,526 | 17,195,564 | 15,028,391 | 13,374,858 | 34,793,801
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 31,066,347 | 10,479,537 | (2,830,010) | (3,338,709) | 33,207,890
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 11,676,197 | 4,662,911 | 3,842,051 | (3,998,784) | 9,064,316
PEO | Dollar Value of Equivalent Payments Reported in Summary Compensation Table [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (435,077) | (96,234) | (514,566) | (435,499) | (335,908)
PEO | Dollar Value of Dividends Paid Prior to Vesting Date [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 464,819 | 368,788 | 226,667 | 445,290 | 545,255
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (1,681,853) | (265,350) | (264,662) | (276,883) | (103,724)
Non-PEO NEO | Pension Adjustments Prior Service Cost |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 230,134 | 149,373 | 135,006 | 182,990 | 207,139
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (3,115,621) | (3,423,531) | (3,489,375) | (3,063,442) | (3,233,944)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 4,987,299 | 2,640,576 | 3,692,881 | 2,698,985 | 7,765,175
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 5,728,425 | 1,434,246 | (482,970) | (573,313) | 7,116,946
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 2,033,581 | 668,465 | 642,447 | (737,029) | 1,834,093
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  | (1,267,373) |  |  |
Non-PEO NEO | Dollar Value of Equivalent Payments Reported in Summary Compensation Table [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (76,670) | (13,211) | (85,739) | (73,188) | (67,999)
Non-PEO NEO | Dollar Value of Dividends Paid Prior to Vesting Date [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ 89,010 | $ 46,153 | $ 41,399 | $ 80,563 | $ 111,397

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(k)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3A -Subparagraph (24)(d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 105 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 9 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 17 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 38: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 39: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 40: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 41: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 42: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 43: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 44: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 46: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 47: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 48: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 4 -Subparagraph (f)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4 Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_PnsnAdjsPrrSvcCstMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_DollarValueOfEquivalentPaymentsReportedInSummaryCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=hca_DollarValueOfDividendsPaidPriorToVestingDateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |